Published in Circulation on August 08, 2000
Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol (2011) 1.83
Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies. J Am Heart Assoc (2014) 1.18
Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis (2014) 0.98
Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag (2009) 0.97
Nebivolol: impact on cardiac and endothelial function and clinical utility. Vasc Health Risk Manag (2012) 0.96
The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist. PLoS One (2013) 0.91
Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Hypertension (2012) 0.87
Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humans. Hypertension (2013) 0.86
Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model. Crit Care (2015) 0.85
Effects of nebivolol therapy on endothelial functions in cardiac syndrome X. Heart Vessels (2010) 0.84
The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension. Br J Clin Pharmacol (2006) 0.84
Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta. Br J Pharmacol (2006) 0.84
Treating coronary disease and the impact of endothelial dysfunction. Prog Cardiovasc Dis (2014) 0.83
Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta. Br J Pharmacol (2009) 0.82
The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients. Can J Cardiol (2007) 0.82
Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium. Br J Pharmacol (2001) 0.81
Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats. Adv Pharmacol Sci (2014) 0.81
Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease. Int J Mol Sci (2015) 0.79
Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers. Vasc Health Risk Manag (2008) 0.79
Functional sympatholysis in hypertension. Auton Neurosci (2014) 0.79
The selective beta1-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities. Br J Pharmacol (2010) 0.78
β₁-Adrenoceptor stimulation suppresses endothelial IK(Ca)-channel hyperpolarization and associated dilatation in resistance arteries. Br J Pharmacol (2013) 0.77
Nebivolol Ameliorates Cardiac NLRP3 Inflammasome Activation in a Juvenile-Adolescent Animal Model of Diet-Induced Obesity. Sci Rep (2016) 0.76
The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis. Med Sci Monit (2012) 0.76
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan. Integr Blood Press Control (2014) 0.76
A comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients. Indian J Pharmacol (2010) 0.75
Chronic Nebivolol Treatment Suppresses Endothelin-1-Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure. Hypertension (2016) 0.75
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data. J Hypertens (2017) 0.75
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet (2000) 3.71
Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J (2001) 2.44
A model of the mechanics of the left ventricle. Ann Biomed Eng (1979) 2.41
17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation (2001) 2.39
Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol (1990) 2.37
Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev (1992) 2.07
Complete recovery in plasma of enzymes lost from the heart after permanent coronary artery occlusion in the dog. Circulation (1990) 2.01
Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: a study in dogs with ventricular pacing and in patients with left bundle branch block. Am Heart J (1995) 1.99
Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med (2001) 1.91
Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation (1998) 1.73
Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience. Neth Heart J (2011) 1.68
Heat shock proteins and cardiovascular pathophysiology. Physiol Rev (2001) 1.62
In the femoral artery bifurcation, differences in mean wall shear stress within subjects are associated with different intima-media thicknesses. Arterioscler Thromb Vasc Biol (1999) 1.62
The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol (2001) 1.62
Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol (1988) 1.60
Assessment of the distensibility of superficial arteries. Ultrasound Med Biol (1990) 1.60
TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study. J Hum Hypertens (2007) 1.59
An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods (1989) 1.58
The human adult cardiomyocyte phenotype. Cardiovasc Res (2003) 1.54
A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. Am Heart J (2000) 1.54
Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. Circ Res (2000) 1.54
Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol (1999) 1.54
Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets. Thromb Haemost (2001) 1.51
Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J (2008) 1.51
Dependence of local left ventricular wall mechanics on myocardial fiber orientation: a model study. J Biomech (1992) 1.46
Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants. Heart (2009) 1.45
Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase. J Biol Chem (1999) 1.45
Microcirculatory investigations to determine the effect of spinal cord stimulation for critical leg ischemia: the Dutch multicenter randomized controlled trial. J Vasc Surg (1999) 1.43
A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol (2013) 1.43
The anterior and the lateral compartmental syndrome of the leg due to intensive use of muscles. Clin Orthop Relat Res (1976) 1.42
Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation (2007) 1.42
Creation of a distal arteriovenous fistula improves microcirculatory hemodynamics of prosthetic graft bypass in secondary limb salvage procedures. J Vasc Surg (1993) 1.40
Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res (2005) 1.39
Changes in myocardial high-energy phosphate stores and carbohydrate metabolism during intermittent aortic crossclamping in dogs on cardiopulmonary bypass at 34 degrees and 25 degrees C. J Thorac Cardiovasc Surg (1990) 1.39
Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat (2002) 1.38
Ketanserin in the treatment of pulmonary hypertension after valvular surgery: a comparison with sodium nitroprusside. Crit Care Med (1989) 1.38
The time sequence of electrical and mechanical activation during spontaneous beating and ectopic stimulation. Eur Heart J (1992) 1.37
Distribution of blood platelets flowing in arterioles. Am J Physiol (1985) 1.31
Blood flow distribution in the left ventricular free wall in open-chest dogs. Basic Res Cardiol (1981) 1.30
Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol (1998) 1.28
17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res (1999) 1.27
Velocity profiles of blood platelets and red blood cells flowing in arterioles of the rabbit mesentery. Circ Res (1986) 1.27
Relation between regional electrical activation time and subepicardial fiber strain in the canine left ventricle. Pflugers Arch (1993) 1.27
A versatile incident illuminator for intravital microscopy. Int J Microcirc Clin Exp (1987) 1.27
Determination of tissue motion velocity by correlation interpolation of pulsed ultrasonic echo signals. Ultrason Imaging (1990) 1.26
Regional fibre stress-fibre strain area as an estimate of regional blood flow and oxygen demand in the canine heart. J Physiol (1994) 1.25
Fluorescent microspheres to measure organ perfusion: validation of a simplified sample processing technique. Am J Physiol (1995) 1.25
Epicardial deformation and left ventricular wall mechanisms during ejection in the dog. Am J Physiol (1982) 1.23
Calcium influx evoked by Ca2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry. Cell Calcium (1992) 1.23
Influence of endocardial-epicardial crossover of muscle fibers on left ventricular wall mechanics. J Biomech (1994) 1.22
Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta (1988) 1.20
Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. Circ Res (1982) 1.18
Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. J Cardiovasc Pharmacol (1988) 1.18
Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation (2000) 1.18
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J (2008) 1.16
Torsion of the left ventricle during the ejection phase in the intact dog. Cardiovasc Res (1984) 1.15
Relation between left ventricular cavity pressure and volume and systolic fiber stress and strain in the wall. Biophys J (1991) 1.14
Short- and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol (1993) 1.13
Terminology for mass transport and exchange. Am J Physiol (1986) 1.13
Angiographic assessment of prospectively determined non-invasive reperfusion indices in acute myocardial infarction. Heart (2000) 1.12
Mouse electrocardiography: an interval of thirty years. Cardiovasc Res (2000) 1.12
Adaptation of cardiac structure by mechanical feedback in the environment of the cell: a model study. Biophys J (1994) 1.11
Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiovasc Res (2000) 1.10
Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life. Br J Cancer (2008) 1.09
Wall shear stress in the human common carotid artery as function of age and gender. Cardiovasc Res (1998) 1.09
Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med (2012) 1.08
Major achievements in cardiology in the past century: influence on Dutch cardiovascular medicine. Neth Heart J (2009) 1.07
Developmental changes in beta-adrenergic modulation of L-type Ca2+ channels in embryonic mouse heart. Circ Res (1996) 1.07
Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice. Genomics (2006) 1.06
Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol (2001) 1.06
Arteriolar vasomotion and arterial pressure reduction in rabbit tenuissimus muscle. Microvasc Res (1987) 1.04
Assessment of LV ejection fraction using real-time 3D echocardiography in daily practice: direct comparison of the volumetric and speckle tracking methodologies to CMR. Neth Heart J (2014) 1.04
A noninvasive method to estimate wall shear rate using ultrasound. Ultrasound Med Biol (1995) 1.03
Description of the deformation of the left ventricle by a kinematic model. J Biomech (1992) 1.03
Porous medium finite element model of the beating left ventricle. Am J Physiol (1992) 1.03
Accumulation of nonesterified fatty acids in ischemic canine myocardium. Am J Physiol (1984) 1.03
The roles of P(2X1)and P(2T AC)receptors in ADP-evoked calcium signalling in human platelets. Cell Calcium (2000) 1.02
Differences in near-wall shear rate in the carotid artery within subjects are associated with different intima-media thicknesses. Arterioscler Thromb Vasc Biol (1998) 1.02
Propagation velocity and reflection of pressure waves in the canine coronary artery. Am J Physiol (1979) 1.01
Muscle blood flow disturbances produced by simultaneously elevated venous and total muscle tissue pressure. Microvasc Res (1980) 1.01
Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. Cardiovasc Res (2001) 1.00
Assessment of fatty acids in dog left ventricular myocardium. Biochim Biophys Acta (1980) 1.00
Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res (2000) 1.00
Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Mol Life Sci (2009) 1.00
Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D. Neth Heart J (2012) 0.99
In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am J Physiol Heart Circ Physiol (2000) 0.99
Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int Immunol (2000) 0.98
Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg (1999) 0.98
Automated detection of local artery wall thickness based on M-line signal processing. Ultrasound Med Biol (1997) 0.98
Non-invasive measurement of mechanical properties of arteries in health and disease. Proc Inst Mech Eng H (1999) 0.97
Concentration profile of blood platelets differs in arterioles and venules. Am J Physiol (1992) 0.97
Age-related changes in carotid artery wall properties in men. Ultrasound Med Biol (1986) 0.97
Relation between torsion and cross-sectional area change in the human left ventricle. J Biomech (1997) 0.97
alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J Biol Chem (2000) 0.97
Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. J Cardiovasc Transl Res (2013) 0.96
Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels. Clin Genet (2006) 0.96
Formation of multilamellar vesicles by addition of tannic acid to phosphatidylcholine-containing small unilamellar vesicles. J Histochem Cytochem (1989) 0.96
Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthy non-diabetic middle-aged women. Diabetologia (2000) 0.96